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Kainate receptors are ligand-gated ion channels that have two major roles in the central nervous system: they mediate 
a postsynaptic component of excitatory neurotransmission at some glutamatergic synapses and modulate transmitter 
release at both excitatory and inhibitory synapses. Accumulating evidence implicates kainate receptors in a variety of 
neuropathologies, including epilepsy, psychiatric disorders, developmental delay, and cognitive impairment. Here, to 
gain a deeper understanding of the conformational changes associated with agonist binding and channel opening, we 
generate a series of Cys substitutions in the GluK2 kainate receptor subunit, focusing on the M3 helices that line the ion 
pore and form the bundle-crossing gate at the extracellular mouth of the channel. Exposure to 50 µM Cd produces direct 
activation of homomeric mutant channels bearing Cys substitutions in (A657C), or adjacent to (L659C), the conserved SYT 
ANL AAF motif. Activation by Cd is occluded by modification with 2-aminoethyl MTS (MTS EA), indicating that Cd binds 
directly and specifically to the substituted cysteines. Cd potency for the A657C mutation (EC50 = 10 µM) suggests that 
binding involves at least two coordinating residues, whereas weaker Cd potency for L659C (EC50 = 2 mM) implies that 
activation does not require tight coordination by multiple side chains for this substitution. Experiments with heteromeric 
and chimeric channels indicate that activation by Cd requires Cys substitution at only two of the four subunits within a 
tetrameric receptor and that activation is similar for substitution within subunits in either the A/C or B/D conformations. 
We develop simple kinetic models for the A657C substitution that reproduce several features of Cd activation as well as 
the low-affinity inhibition observed at higher Cd concentrations (5–20 mM). Together, these results demonstrate rapid and 
reversible channel activation, independent of agonist site occupancy, upon Cd binding to Cys side chains at two specific 
locations along the GluK2 inner helix.
Cadmium opens GluK2 kainate receptors with 
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Introduction
Ionotropic glutamate receptors (iGluRs) are tetrameric pro-
teins in the pore loop superfamily of ion channels that also in-
cludes voltage-gated sodium, calcium, and potassium channels 
as well as cyclic nucleotide–gated channels, TRP channels, and 
others (Hille, 2001). Structural analysis of iGluRs has revealed 
a modular organization with each subunit in the tetramer con-
tributing to four distinct domains (Traynelis et al., 2010). The 
amino terminal domain (ATD) and ligand-binding domain (LBD) 
are extracellular. The transmembrane domain (TMD) forms the 
ion-conducting pore (Huettner, 2015), and the carboxy-terminal 
domain (CTD) is intracellular. In the closed state, tight associa-
tion of inner helices at the bundle crossing occludes the conduc-
tion pathway, denying ions passage through the pore (Doyle et 
al., 1998; Sobolevsky et al., 2009). Conformational changes in the 
LBD contingent on agonist binding (Mayer, 2017; Twomey and 
Sobolevsky, 2018) open the channels by pulling on short linkers 
that splay apart and deform the inner (M3) helix bundle to re-
move the occlusion and provide a route for water and ions into 
the central cavity (Chen et al., 2017; Twomey et al., 2017).
Despite limited overall sequence identity among iGluR sub-
types (Traynelis et al., 2010), the bundle-crossing occlusion zone 
near the extracellular end of M3 comprises the longest identical 
segment across the different subunits. Throughout the paper we 
will use the numbering system in Fig. 1 A to refer to homologous 
M3 positions relative to the first conserved residue (S = 1) of the 
nine–amino acid SYT ANL AAF motif. Initial evidence that the M3 
helix plays a role in glutamate receptor gating came from analysis 
of the Lurcher mutant mouse in which an A to T point mutation 
at position 8 of this motif (A8T) in the orphan delta subunit re-
sults in constitutive channel activity (Zuo et al., 1997; Wollmuth 
et al., 2000). Subsequent work showed that substitution of the 
homologous A8 alanine residue in AMPA, kainate, and NMDA re-
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ceptors increases apparent affinity for agonists, reduces desensi-
tization, slows the rate of receptor deactivation, and allows some 
degree of constitutive channel opening in the absence of added 
agonist (Kohda et al., 2000; Taverna et al., 2000; Schwarz et al., 
2001; Klein and Howe, 2004; Schmid et al., 2007). Interest in how 
this segment contributes to channel operation has been height-
ened by growing evidence that the LBD–TMD linkers and extra-
cellular ends of M1, M3, and M4 serve as targets for a number 
of iGluR subtype-selective allosteric modulators (Yelshanskaya 
et al., 2016; Wang et al., 2017; Perszyk et al., 2018). In addition, 
recent studies have identified a spectrum of neuropathologies 
that can result from missense mutations at, or near, the Lurcher 
site of several human iGluR subunits (Li et al., 2016; Fernández-
Marmiesse et al., 2018; Fry et al., 2018), including the kainate 
receptor subunit GluK2 (Guzmán et al., 2017). This accumulating 
evidence has spurred recent efforts to understand how sponta-
neous and engineered mutations in the bundle crossing and LBD–
TMD linker segments affect iGluR function (Alsaloum et al., 2016; 
Yelshanskaya et al., 2017; Ladislav et al., 2018).
One approach to evaluating structural changes associated 
with channel gating involves cysteine scanning mutagene-
sis in which each amino acid in a protein segment is individ-
ually replaced with cysteine residues and the resulting set of 
mutant constructs tested for accessibility to modification by 
cysteine-reactive MTS reagents (Akabas, 2015). Differences 
in accessibility to MTS reagent modification, or in the rate of 
modification, between different gating states of the channel 
can thus provide information about the conformational changes 
that underlie the gating state transitions. In the course of these 
studies, it has sometimes been observed that cysteines substi-
tuted at specific locations allow fortuitous coordination of metal 
ions that can stabilize a specific conformational state (Liu et al., 
1997; Holmgren et al., 1998; Zhou et al., 2015). In the case of iG-
luRs, a coordination site for copper ions that locks channels in 
the closed configuration can be formed by cysteine substitution 
at two distinct locations along the inner helix of NMDA recep-
tor GluN1 (T3C) and GluN2 (L-1C) subunits (Sobolevsky et al., 
2002). Both sites must be substituted in a heteromeric receptor 
in order for copper to bind, and recovery is slow without expo-
sure to reducing agents (Sobolevsky et al., 2002). In addition, 
coapplication of Cd was shown to inhibit agonist-evoked current 
flow through homomeric GluA1 AMPA receptors with L-4C or 
A7C substitutions (Sobolevsky et al., 2004). Exposure to Cd in 
the absence of agonist had little effect, but recovery from inhi-
bition was independent of agonist, suggesting that Cd did not 
become trapped when cells were switched to agonist-free solu-
tions (Sobolevsky et al., 2004).
In the present study, we have examined the action of Cd on 
homomeric GluK2 kainate receptors with cysteine substitutions 
from W-8C to V12C near the extracellular end of the M3 helix. 
Our results show that exposure to Cd alone directly activates 
receptors with substitutions at two specific positions (A8C and 
L10C) within the bundle crossing occlusion zone. Furthermore, 
using chimeric subunits that combine the extracellular ATD 
and LBD from NMDA receptors with the GluK2 TMD and CTD 
(Wilding et al., 2014), we find that activation by Cd only requires 
cysteine substitution in two of the four subunits within a tetram-
eric receptor and that susceptibility to activation by Cd is essen-
tially equivalent for cysteine substitutions to subunits in either 
the A/C or B/D conformation (Fig. 1).
Materials and methods
Complementary DNA (cDNA) constructs, cell culture, 
and transfection
WT GluK2(R) cDNA provided by Steve Heinemann (Salk Insti-
tute, La Jolla, CA) was subcloned into pcDNA3 for expression in 
human embryonic kidney (HEK293) cells. Conversion to gluta-
mine at the Q/R site and cysteine substitutions along the GluK2 
M3 helix were prepared as described (Wilding et al., 2008) using 
the QuickChange XL site-directed mutagenesis kit (Agilent Tech-
nologies). Additional subunit cDNAs provided by Mark Mayer 
(National Institutes of Health, Bethesda, MD), Peter Seeburg 
(Max Planck Institute, Heidelberg, Germany), and Stefano Vicini 
(Georgetown University, Washington, DC) were used to construct 
chimeric subunits as previously described (Wilding et al., 2014). 
Residue substitutions in chimeric subunits were generated by 
PCR. All constructs were verified by sequencing in the Washing-
Figure 1. The M3 helix sequence conservation. (A) Alignment of ionotropic 
glutamate receptor subunit inner helix (M3) sequences. Numbers to the right 
denote position of the final residue from the N-terminal methionine. Homol-
ogous positions are numbered above the sequences relative to the first con-
served residue (S = 1) of the nine–amino acid SYT ANL AAF motif. Yellow high-
lights identical residues, and gray highlights positions of nonidentity within 
the GluN2 and GluK4/5 subfamilies. The A8 Lurcher site is marked with a red 
asterisk. In the closed conformation, the M3 helix extends to approximately 
+17 and +12 in the A/C and B/D configurations, respectively, as indicated by 
gray cylinders above the sequence. A horizontal line below the sequence 
indicates the closed conformation bundle crossing occlusion. (B) The GluK2 
homology model based on the homomeric GluA2 AMPA receptor closed state 
x-ray structure. The A/C configurations are shown in green and blue; B/D 
configurations are shown in red and yellow. The bottom right box shows an 
expanded view of the linkage zone between the LBD and TMD of the B and D 
subunits. The top right box shows B and D subunit M3 helices with A8C and 
WT A7 and L10 side chains displayed.
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ton University protein and nucleic acid chemistry laboratory. 
The HEK293 cells at ∼60% confluence were transfected with 1–3 
µg of subunit cDNA using lipofectamine 2000 (Thermo Fisher 
Scientific). Coexpression of GFP from a second plasmid was used 
to identify transfected cells. On the day after transfection, cells 
were dissociated with mild protease treatment and replated at 
low density on nitrocellulose-treated 35-mm dishes (Wilding et 
al., 2008). Physiological recordings were obtained from green 
fluorescent cells 24–48 h after replating.
Electrophysiology
Cultures were perfused with Tyrode’s solution (in mM): 150 NaCl, 
4 KCl, 2 MgCl2, 2 CaCl2, 10 glucose, 10 HEP ES, pH 7.4, with NaOH. 
Whole-cell electrodes were filled with internal solution (in mM): 
140 Cs-glucuronate, 10 EGTA, 5 CsCl, 5 MgCl2, 5 ATP, 1 GTP, 10 
HEP ES, pH adjusted to 7.4, with CsOH. Currents were recorded 
with an Axopatch 200A amplifier controlled by pClamp software 
(Molecular Devices). Agonist and Cd applications were made in 
control extracellular solution (160 mM NaCl, 2 mM CaCl2 and 
10 mM HEP ES, pH 7.4, with NaOH) delivered by gravity-driven 
local perfusion from an eight-barreled pipette positioned near 
the recorded cell (time constant for solution exchange ∼50–100 
ms). All measurements were made relative to holding current 
in the control solution. Current–voltage (I-V) relations were 
generated and analyzed from triangle wave ramps as described 
(Lopez et al., 2013).
Figure 2. Cd inhibits WT GluK2(Q) and GluK2(R). (A) Whole-cell currents 
evoked by 10 µM kainate in an HEK cell transfected with GluK2(R). Kainate 
was applied as indicated by the open bars. Solid bars indicate coapplication 
of Cd at 10, 50, 100, and 500 µM and 1 and 5 mM. Holding potential is −80 
mV. (B) Current (mean ± SEM) recorded during Cd coapplication plotted as 
a fraction of control current immediately before Cd exposure (five cells for Q 
and four cells for R). Smooth curves are the best fit of I/Icontrol = 100/(1 + ([Cd]/
IC50)n), where IC50 is the concentration that produced half-maximal inhibition 
and n is the slope factor. (C) Outward current evoked by kainate in a different 
cell held at +40 mV was inhibited by brief exposure to 5 mM Cd as indicated 
by the solid bar.
Figure 3. Cd activates kainate receptors with inner helix cysteine sub-
stitutions. (A) Whole-cell current evoked by 10 µM kainate (open bar) and 
no effect of 50 µM Cd alone (red bars) in an HEK cell transfected with WT 
GluK2(Q). (B) Currents evoked by exposure to kainate and Cd in a different cell 
transfected with GluK2(Q) A8C plotted at the same current scale. (C) Coap-
plication of 50 µM Cd and 10 µM kainate compared with Cd alone. In A–C, 
holding potential is −80 mV. (D and E) Current evoked by 10 µM kainate or 
50 µM Cd during voltage ramps from −150 to +120 mV. (F) Current evoked by 
50 µM Cd alone as a fraction of current evoked by 10 µM kainate alone (mean 
± SEM, 4–114 cells per construct) for GluK2(Q) (open bars) and GluK2(R) (solid 
bars) WT or mutant, with Cys substitution at each position from W641C (−8) 
to V661C (+12). Crosses denote positions where exposure to either kainate 
or Cd failed to evoke any change in holding current. Symbols indicate current 
ratios significantly greater than (*) or less than (#) WT (P < 0.05, ANO VA on 
ranks, post hoc Dunn’s test). (G) Current evoked by coapplication of Cd and 
kainate as a fraction of kainate alone (4–21 cells per construct).
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For concentration–inhibition experiments, the current recorded 
during exposure to agonist and Cd was plotted as a fraction of 
control current evoked by agonist alone. Concentration–inhibi-
tion results were fit with the following equation:
 I / I control = m + (1 − m ) / ( 1 +  ( [ Cd ] / IC 50 ) n ) , 
where IC50 is the Cd concentration producing half-maximal inhi-
bition, n is the slope factor, and m is a baseline adjustment used 
when current during exposure to Cd was less than the holding 
current in control solution. Steady-state currents evoked by Cd 
were normalized to the maximal Cd response and fit with the fol-
lowing equation: I/Imax = (1/(1 + (EC50/[Cd])n))/(1 + ([Cd]/IC50)b), 
where Imax is the maximal current evoked by Cd; EC50 and IC50 
are the Cd concentrations producing half-maximal activation 
and inhibition, respectively; and n and b are the slope factors for 
activation and inhibition.
Concentration dependence for chimeric subunits exhibiting 
both activation and inhibition by Cd was fit with I/Imax = m + ((1/
(1 + (EC50/[Cd])n) − m)/(1 + ([Cd]/IC50)b)), where EC50 and IC50 are 
the half-maximal concentrations for activation and inhibition, 
respectively; n and b are the slope factors or Hill coefficients for 
activation and inhibition; and m is the minimum current base-
line. Coupling energies were calculated from EC50 values for dou-
ble mutant cycles as follows (Kash et al., 2003; Gleitsman et al., 
2008; Venkatachalan and Czajkowski, 2008):
 Ω ( ΔΔG ) = − RT ln [    (   EC 50  wt *  EC 50  double mutant )    _______________________ (   EC 50  mutant 1 *  EC 50  mutant 2 )  ] . 
Unitary conductance was estimated as described previously 
(Wilding et al., 2008; Lopez et al., 2013) from plots of current 
variance versus mean current using data filtered at 2 kHz (−3 dB, 
four-pole Bessel) and digitized at 10 kHz during slow applications 
of agonist or Cd. Variance was calculated for 100-ms intervals 
after subtracting a straight line fit to correct for steady ampli-
tude changes (Bean et al., 1990). When open probability (Po) 
is low (∼0.2 or less), the variance versus mean plot is approx-
imately linear with slope equal to the unitary current (Bean et 
al., 1990; Lingle, 2006). For Po > 0.2, the relationship of variance 
(σ2) to mean current (I) is parabolic: σ2 = i * I – I2 /N, where i is 
the estimated unitary current, and N is the estimated number 
of channels (Sigworth, 1980). Maximal Po was estimated from 
Po = Imax/(i * N).
Results are reported as mean ± SEM, and significance was 
assigned for P < 0.05. One-way and two-way ANO VA and t tests 
were performed with SigmaStat (Systat Software). Curve fits 
using different numbers of parameters were evaluated by the 
ratio of residual variance test, F statistic (Swartz et al., 1992).
Modeling
We used Modeller version 9.18 (Eswar et al., 2008) with two-
fold symmetry constraints for the A/C and B/D conformations 
to model GluK2(R) A8C on the homomeric GluA2 open state 
structure (PDB accession no. 5WEO) from the Sobolevsky lab-
oratory (Twomey et al., 2017). Structures are displayed with 
PyMol. Kinetic model simulations were performed in Excel by 
numerical integration of entry and exit rate equations for each 
postulated state.
Online supplemental material
Fig. S1 shows Cd activation of GluK2(Q) A8C receptors that in-
clude a second mutation in the LBD that reduces agonist potency 
(Mah et al., 2005). Fig. S2 illustrates inhibition of GluK2 A8S, T, 
Y, or F by increasing concentrations of Cd. Fig. S3 shows kinetic 
model simulations that reproduce several features observed for 
activation and inhibition of receptors with A8C substitutions to 
Figure 4. Concentration dependence of Cd activation. (A) Whole-cell cur-
rents evoked by 500, 50, 5, and 0.5 µM Cd alone in an HEK cell transfected 
with GluK2(Q) A8C. Inset shows exponential fits to the onset (red) and recov-
ery (blue) phases of current evoked by 50 µM Cd shown on an expanded time 
scale. Holding potential is −80 mV. (B) Onset and recovery of low-affinity 
inhibition during exposure to 20 and 5 mM Cd in a different cell transfected 
with GluK2(Q) A8C. (C) Plot of steady-state current (mean ± SEM) as a fraction 
of the maximal Cd-evoked response. Smooth curve is the best simultaneous 
fit of I/Imax = (m/(1 + (EC50/[Cd])n))/(1 + ([Cd]/IC50)b) to the data for A8C sub-
stitution of both GluK2(Q) and GluK2(R), where EC50 = 7.3 ± 1.4 µM and IC50 = 
25 ± 5.4 mM are the concentrations for half-maximal activation and inhibition, 
respectively; n = 1.6 ± 0.4 and b = 1.3 ± 0.4 are the slope factors; and m = 0.86 
± 0.03 is the maximal steady-state current. Individual fits to Q (11 cells) and 
R (12 cells) data sets were not statistically superior by F test. Cd activated 
GluK2(Q) L10C with weaker potency (EC50 = 1.8 ± 0.3 mM, n = 1.2 ± 0.2; IC50 = 
26 ± 7.1 mM, b = 1.9 ± 0.5; m set to 1; 12 cells).
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one or both chimeric subunit. Table S1 provides a summary of 
parameters derived from these simulations.
Results
Cd inhibits WT GluK2(Q) and GluK2(R)
Previous work showed that WT native and recombinant kainate 
receptors are potently inhibited by the trivalent ions La and Gd 
with an IC50 of ∼3 µM (Huettner et al., 1998). In contrast, diva-
lent cations including Ni, Co, Cu, Cd, and Zn have a substantially 
weaker inhibitory effect on WT kainate receptors, typically 
causing <50% inhibition at 100 µM (Huettner et al., 1998; Mott 
et al., 2008; Veran et al., 2012). Before evaluating the effect of 
Cd on Cys substitution mutants, we determined the concen-
tration dependence of inhibition at homomeric recombinant 
kainate receptors expressed in HEK293 cells after transfection 
of cDNA encoding WT GluK2. As shown in Fig. 2, exposure to 
Cd produced dose-dependent inhibition of whole-cell currents 
mediated by homomeric GluK2 with either glutamine (Q) or 
arginine (R) at the Q/R editing site. Average current evoked by 
10 µM kainate was −2.0 ± 0.9 nA (R) and −2.8 ± 0.5 nA (Q), and 
inhibition by Cd was somewhat more potent at GluK2(R) than at 
GluK2(Q) with half-maximal values of 250 ± 38 µM and 890 ± 
83 µM, respectively (five cells for Q and four cells for R). In a few 
cells, we also tested for possible voltage dependence of Cd inhibi-
tion by coapplication of Cd and kainate at a holding potential of 
+40 mV where current flows outward through kainate receptor 
channels. As shown in Fig. 2 C, Cd coapplication produced essen-
tially equivalent inhibition at positive holding potentials as was 
observed at −80 mV (Fig. 2, A and B), indicating a lack of voltage 
dependence and suggesting that Cd binding responsible for inhi-
bition does not occur within the conduction pathway (Huettner 
et al., 1998; Mott et al., 2008). In addition, exposure to 50 µM 
Cd alone caused no significant change in the holding current re-
corded from untransfected cells or in cells transfected with WT 
GluK2(Q) or GluK2(R) (Fig. 3 A).
Cd activates GluK2(Q) and GluK2(R) with Cys substitutions at 
specific residues
Previous studies have analyzed NMDA (Beck et al., 1999; Jones et 
al., 2002; Yuan et al., 2005; Sobolevsky et al., 2007; Chang and 
Kuo, 2008) and AMPA (Sobolevsky et al., 2004) receptors with 
Cys substitutions in the M3 transmembrane helix and linker to 
the S2 extracellular segment. To test for commonalities among 
iGluRs, we generated a series of point mutations along the M3 
helix of both edited (R) and unedited (Q) GluK2 kainate receptor 
subunits, scanning from W641C (−8) to V661C (+12; Fig. 1). Ho-
momeric receptors with Cys substitutions at most locations were 
functional when expressed by transient transfection in HEK293 
cells as determined by activation of whole-cell current during 
Table 1. Half-maximal concentrations for Cd activation and inhibition
Construct EC50 (µM) Slope, n IC50 (mM) Slope, b Cells (no.)
K2(Q) WT (KA-evoked) 0.89 ± 0.08 1.1 ± 0.1 5
K2(R) WT (KA-evoked) 0.25 ± 0.04 1.0 ± 0.1 4
K2(Q&R) A8C 7.3 ± 1.4 1.6 ± 0.4 25 ± 5.4 1.3 ± 0.4 23
K2(Q) L10C 1,800 ± 300 1.2 ± 0.2 26 ± 7.1 1.9 ± 0.5 12
N1/K2 A8C + N2B/K2 A8C 5.6 ± 1.7 0.9 ± 0.1 1.1 ± 0.2 1.8 ± 0.4 21
N1/K2 A8C + N2B/K2 47 ± 8 1.0 ± 0.2 13 ± 10 0.9 ± 0.4 14
N1/K2 + N2B/K2 A8C 27 ± 9 0.9 ± 0.1 1.1 ± 0.2 1.8 ± 0.4 14
Table 2. Time constants for Cd activation and inhibition
Construct Activation (s) Cells (no.) [Cd] Inhibition (s) Cells (no.) [Cd]
Tau on Tau off Tau on Tau off
GluK2 WT (KA-evoked) 0.51 ± 0.10 2.49 ± 0.48 8 5 mM
GluK2 A8C 0.81 ± 0.06 8.41 ± 1.07 94 50 µM
0.10 ± 0.01 9.91 ± 3.10 19 20 mM 0.33 ± 0.04 0.60 ± 0.07 19 20 mM
K2(Q) L10C 0.71 ± 0.15 1.52 ± 0.25 16 1 mM
N1/K2 A8C + N2B/K2 A8C 0.90 ± 0.23 5.95 ± 0.91 35 50 µM
0.10 ± 0.01 8.68 ± 2.73 11 5 mM 0.39 ± 0.05 1.12 ± 0.13 11 5 mM
N1/K2 A8C + N2B/K2 0.88 ± 0.13 2.91 ± 0.63 30 50 µM
0.11 ± 0.02 1.87 ± 0.12 13 5 mM 0.37 ± 0.05 0.67 ± 0.06 13 5 mM
N1/K2 + N2B/K2 A8C 0.97 ± 0.17 3.24 ± 0.60 33 50 µM
0.09 ± 0.02 3.91 ± 0.87 10 5 mM 0.22 ± 0.02 0.66 ± 0.06 10 5 mM
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exposure to 10 µM kainate. Only the A4C and L6C mutants failed 
to function in both the Q and R form, whereas the S0C and T11C 
substitutions were functional in the Q but not the R form. In addi-
tion to kainate, each of the Cys substitution mutants were tested 
with exposure to 50 µM Cd alone (Fig. 3, B, C, and F) and 50 µM 
Cd together with 10 µM kainate (Fig. 3, C and G). Consistent with 
our results for WT receptors (Figs. 2 and 3 A), Cd had little or no 
effect when applied alone and caused modest (∼10–40%) inhibi-
tion of current evoked by kainate (Huettner et al., 1998) in cells 
transfected with most of the mutant constructs (Fig. 3, F and G). 
However, exposure to Cd produced substantially different effects 
for receptors with Cys substitutions at a few specific M3 loca-
tions. In particular, exposure to Cd alone significantly reduced 
the holding current in cells expressing GluK2 subunits with A7C 
substitution (Fig. 3 F) and activated large currents in cells trans-
fected with A8C or L10C substitution mutants (Fig. 3).
For receptors with A8C or L10C substitutions, the currents ac-
tivated by kainate or by Cd alone displayed similar I-V relations 
(Fig. 3, D and E). As for WT GluK2(Q) and GluK2(R), the I-V re-
lations recorded for kainate and for Cd alone in cells expressing 
homomeric GluK2(Q)A8C (Fig. 3 D) or L10C showed prominent 
rectification, owing to pore block by cytoplasmic polyamines 
(Traynelis et al., 2010). In contrast, the I-V relations were nearly 
linear in cells transfected with the A8C (Fig. 3 E) or L10C muta-
tions of GluK2(R), which resists polyamine block (Traynelis et 
al., 2010). Together, these results provide strong evidence that 
currents evoked by exposure to Cd arise from direct activation 
of mutant channels and not from some indirect effect enabled by 
mutant subunit expression. Moreover, the rectification observed 
for unedited (Q) receptors demonstrates that Cys substitution 
at A8 or L10, as well as Cd activation of mutant receptors, does 
not perturb the elements required for polyamine block, as can 
occur with M3 residue substitutions closer to the central cavity 
(Wilding et al., 2010).
Bar plots in Fig. 3, F and G, summarize the action of 50 µM 
Cd alone or together with 10 µM kainate on the series of M3 Cys 
substitutions. On average, for the A8C substitution, the current 
evoked by Cd was similar in amplitude to current elicited by ka-
inate plus Cd, suggesting that 50 µM Cd alone achieves nearly 
maximal activation. By contrast, for the L10C substitution, cur-
rents evoked by coapplication of Cd and kainate (Fig. 3 G) were 
substantially larger on average than the sum of currents acti-
vated by Cd alone and kainate alone (Fig. 3 F), suggesting syn-
ergy between Cd and kainate in promoting channel activation 
for this substitution.
To determine the concentration dependence of Cd activation, 
we recorded currents evoked by 0.5 µM to 20 mM Cd in cells 
transfected with the A8C substitution in GluK2(Q) or GluK2(R) or 
with the GluK2(Q) L10C mutant. As shown in Fig. 4, Cd activated 
both the edited (R) and unedited (Q) forms of the A8C substi-
tution mutant with half-maximal potency of ∼10 µM (Table 1). 
Separate fits to the data points for Q and R isoforms were not sta-
tistically superior to the simultaneous fit of both datasets shown 
in Fig. 4 C (F test, P > 0.05). A second measure of Cd affinity came 
from exponential fits to the onset (τon) and recovery (τoff) phases 
of currents evoked by 50 µM Cd (Fig. 4 A, inset, and Table 2). For 
the simplest model in which activation results from binding a 
single Cd: Kd = τon * [Cd]/(τoff − τon), where the dissociation con-
stant (Kd) is estimated to be 11.2 ± 1.3 µM (87 cells). The potency 
for Cd activation was substantially weaker for the L10C than the 
A8C substitution mutant of GluK2, as judged either by the higher 
L10C mutant Cd EC50 of 1.8 ± 0.3 mM (Fig. 4 C) or the Kd of 1.7 ± 
0.7 mM (16 cells) estimated from onset and recovery time con-
stants of currents evoked by 1 mM Cd. At the highest Cd doses 
tested, homomeric channels with either A8C or L10C substitu-
tions exhibited partial inhibition of steady-state currents (Fig. 4, 
Figure 5. The M3 Cys substitutions increase agonist potency, and Cd 
coapplication has a differential effect on L10C versus A8C. (A) Whole-cell 
currents evoked by decreasing concentrations of kainate (open bars) from 
10 µM to 2.5 nM in an HEK cell transfected with GluK2(Q) L10C. (B) In a differ-
ent cell, the same agonist concentrations were applied together with 50 µM 
Cd (cyan bars). Note the increased responses to low doses. (C) Plots of current 
evoked by kainate (mean ± SEM) normalized to the maximal response for 
each condition. Smooth curve is the best fit of I/Imax = 1/(1 + (EC50/[kainate])
n), where EC50 is the concentration for half-maximal activation and n is the 
slope factor. Activation of WT receptors is half-maximal at 1.5 µM (data taken 
from Wilding et al., 2005). Homomeric M3 A8C or L10C substitution increased 
kainate potency by ∼12.5-fold. Individual fits to the results for K2(Q) A8C (5 
cells), K2(R) A8C (3 cells), and K2(Q) L10C (10 cells) were not significantly bet-
ter than the simultaneous fit to all three data sets with EC50 = 120 ± 9 nM and 
n = 0.8 ± 0.04. Coapplication of 50 µM Cd to K2(Q) L10C (nine cells) produced 
an additional increase in apparent agonist potency of ∼4.5-fold (EC50 = 26 ± 
3 nM), whereas agonist potency was unchanged with coapplication of 0.5 µM 
Cd to K2(Q) A8C (nine cells).
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B and C, and see below); however, inhibition of mutant receptors 
exhibited substantially weaker potency than for homomeric WT 
receptors (Fig. 2 and Table 1).
A8C and L10C substitutions increase agonist potency
Previous work has shown that inner helix mutations, including 
A8 substitutions (Kohda et al., 2000; Taverna et al., 2000; Klein 
and Howe, 2004), can increase iGluR agonist potency, highlight-
ing the mechanistic linkage between agonist binding to the LBD 
and conformational changes at the bundle crossing. To determine 
whether A8C and/or L10C substitutions affected agonist potency 
at GluK2, we recorded currents evoked by 2.5 nM to 160 µM ka-
inate in cells transfected with GluK2(Q) A8C, GluK2(R) A8C, and 
GluK2(Q) L10C. As shown in Fig. 5, kainate was >10-fold more 
potent at receptors with A8C or L10C substitution as compared 
with WT (Jones et al., 1997; Wilding et al., 2005). Indeed, the 
concentration dependence for all three constructs was similar 
enough that individual fits to data for each one alone were not 
statistically superior to a simultaneous fit of all three data sets 
with an EC50 = 120 ± 9 nM (F test; Fig. 5).
In addition to recording currents evoked by kainate alone, 
we also evaluated currents elicited by kainate together with a 
low dose of Cd (Fig. 5), either 50 µM for the L10C substitution or 
0.5 µM for the A8C substitution. These values were chosen near 
the “foot” of the respective concentration–response relations 
for current activation by Cd alone (Fig. 4). For receptors with 
the L10C substitution, adding 50 µM Cd caused an ∼4.5-fold in-
crease in kainate potency (EC50 = 26 ± 3 nM); however, for the 
A8C substitution, adding 0.5 µM Cd caused no significant change 
in EC50 for activation by kainate (Fig. 5 C). In addition, for the 
A8C substitution, we did not observe evidence for synergy be-
tween 10 µM kainate and submaximal doses of Cd (0.5 or 5 µM). 
Currents evoked by coapplication of kainate and 0.5 or 5 µM Cd 
in cells expressing GluK2 A8C were less than or equal in ampli-
tude to the sum of current evoked by kainate alone and Cd alone 
(Fig. 6, A and C), whereas for L10C, coapplication of kainate plus 
Cd evoked current that was larger than the sum of current elic-
ited by kainate alone and Cd alone (Fig. 6, B and C).
To determine whether the increase in agonist potency ob-
served for receptors with M3 Cys substitutions (Fig.  5) was 
somehow required for activation by Cd, we added an E to D sub-
stitution in the LBD (E738D) that was previously found to reduce 
agonist potency (Mah et al., 2005). As shown in Fig. S1, current 
activation by 50  µM Cd alone persisted in the GluK2(Q) A8C 
E738D double mutant despite a substantial reduction in kainate 
potency (EC50 = 28 ± 5 µM). Thus, Cd activation is not restricted 
to receptors with higher agonist affinity. Indeed, the ∼230-fold 
change in EC50 from 120 nM for K2(Q) A8C to 28 µM for K2(Q) 
A8C E738D is similar in magnitude to the 270-fold change previ-
ously reported for K2(Q) E738D compared with WT GluK2 (Mah 
et al., 2005). Based on these agonist EC50 values (Kash et al., 2003; 
Gleitsman et al., 2008; Venkatachalan and Czajkowski, 2008), we 
estimate a coupling energy (ΔΔG) <100 cal/mol for the A8C and 
E738D mutations, suggesting a lack of strong interaction between 
the residues at these two positions.
Cd opens the channel
Previous work suggests that iGluRs with amino acid substitutions 
at the A8 Lurcher site exhibit lower unitary conductance than 
WT receptors (Kohda et al., 2000; Murthy et al., 2012). In addi-
tion, editing at the Q/R site reduces conductance of WT GluK2(R) 
<1 pS, making it difficult to resolve unitary currents above the 
background noise (Howe, 1996; Huettner, 2015). Therefore, to 
provide an initial characterization of channel activity promoted 
by exposure to Cd, we performed fluctuation analysis (Lopez et 
al., 2013) of whole-cell currents evoked by 50 and 500 µM Cd or 
10 µM kainate in cells expressing edited (R) receptors with A8C 
substitution, as well as currents evoked by 10 µM kainate plus 
50 µM Cd in cells transfected with GluK2(Q) L10C (Fig. 7).
For the L10C substitution, most plots of current variance (σ2) 
versus mean current (I) followed a parabolic trajectory (Sigworth, 
1980): σ2 = i × I – I2/N, where i and N are the estimated unitary 
current and number of channel, respectively (Fig. 7 and Table 3). 
Cd alone, kainate alone, and Cd plus kainate activated channels 
with similar estimated unitary conductance (∼1 pS), and differ-
ences in maximal current amplitude between Cd, kainate, and 
Cd plus kainate largely reflected differences in open probability: 
Po = Imax/(i * N). On average, for GluK2(Q) L10C, the unitary con-
ductance with Cd was at least 80% of that for kainate, while the 
ratio of open probability with Cd to kainate (Po Cd/Po K) was 0.4 
± 0.1 for 50 µM Cd alone, 1.7 ± 0.5 for 500 µM Cd alone, and 3.9 ± 
1.3 for kainate plus 50 µM Cd (Table 3).
Figure 6. Synergistic activation by Cd and kainate at 
GluK2 L10C. (A and B) Whole-cell currents evoked by Cd 
alone (red bars), 10 µM kainate (open bars), or kainate plus 
Cd (cyan bars) in HEK cells expressing GluK2(Q) A8C (A) or 
GluK2(Q) L10C (B). Note that for the L10C substitution (B), 
current evoked by kainate plus Cd was larger than the sum of 
current evoked by kainate alone (black arrow) and Cd alone 
(red arrow). (C) Currents evoked by Cd alone and kainate plus 
Cd in the same cell plotted as a fraction of the current evoked 
by kainate alone for GluK2 A8C with either 5 µM Cd (open 
symbols, 10 cells for Q) or 50 µM Cd (20 cells; 13 for Q and 7 
for R) and GluK2 L10C with.50 µM Cd (15 cells; 10 for Q and 
5 for R). Results for individual cells are plotted in gray and 
connected by lines (open symbols are Q, and solid symbols 
are R); larger colored symbols plot mean ± SEM. Note the 
y-axis log scale. Asterisk denotes significant difference from 
Cd alone (P < 0.00003, paired t test).
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For the A8C substitution, variance versus mean plots were es-
sentially linear, suggesting a relatively low Po (Lingle, 2006). In 
contrast to L10C, the slopes of GluK2 A8C variance versus mean 
plots were steeper for responses evoked by kainate than by 50 or 
500 µM Cd, indicating a higher unitary conductance for channel 
activation by kainate (Fig. 7 and Table 3). Assuming that kainate 
and Cd act on the same number of channels, the higher maximal 
macroscopic current evoked by Cd reflects an ∼20- to 30-fold 
higher open probability as compared with kainate: (Po(Cd)/Po(K)) 
= (ICd * iK)/(IK * iCd). In contrast, the unitary conductance for Cd 
alone was only 30–40% as large as for kainate (Table 3).
Specificity for Cys substitution and occlusion by MTS reagents
Cd and other metal ions can bind directly to Cys side chains 
(Holm et al., 1996; Rulíšek and Vondrášek, 1998) suggesting that 
Cys residues substituted at A8 or L10 may contribute to a novel 
Cd binding site. However, as mentioned above, residue changes 
at positions 8 and 10 (Fig. 5), as well as at a number of other M3 
locations, can alter receptor properties even without exposure 
to metal ions (Kohda et al., 2000; Taverna et al., 2000; Klein and 
Howe, 2004; Chang and Kuo, 2008), raising the possibility that 
conformational changes induced by substitutions in the bundle 
crossing might alter the effect of Cd binding elsewhere on the 
channel or expose novel cryptic Cd interaction sites that are not 
accessible in WT receptors. To determine whether activation by 
Cd required A8 replacement with Cys, we tested receptors in 
which A8 was substituted with other residues including Ser, Thr, 
Phe, and Tyr. As shown in Fig. 8, large inward currents evoked 
by exposure to 50 µM Cd alone (Fig. 8 A) or together with 10 µM 
kainate (Fig. 8 B) were only observed for receptors with A8C sub-
stitution. In addition, at higher doses (500 µM and 5 mM), Cd 
alone reduced the holding current and inhibited evoked current 
when coapplied with kainate to cells expressing the A8S, T, Y, or 
F substitution mutants (Fig. S2).
As a further test of the idea that Cd directly interacts with 
the Cys side chain substituted for A8 or L10, we compared the 
action of Cd before and after exposure to 100 µM MTS EA, a sulf-
hydryl-reactive compound that modifies free cysteine residues 
to produce a positively charged side chain approximately the size 
of lysine (Fountain and North, 2006; Akabas, 2015). For both the 
A8C and L10C substitutions, treatment with MTS EA significantly 
reduced the amplitude of Cd-evoked current (Fig. 8, C–E). In the 
case of GluK2(Q) A8C, there was little effect on current evoked 
by kainate alone or on the holding current (Fig. 8 D), whereas 
for the L10C substitution, both the holding current and the 
current evoked by kainate were increased following exposure 
to MTS EA (Fig. 8, C and E). Thus, Cys modification by MTS EA 
reduces susceptibility to Cd activation of receptors with A8C or 
L10C substitutions.
Cd activation of heteromeric receptors
Homomeric mutant receptors with one M3 helix substitution per 
subunit would have a total of four novel introduced cysteines. To 
test whether Cys substitutions on all four subunits is required, 
we first evaluated the effects of Cd on heteromeric receptors pro-
duced in HEK cells cotransfected with mutant GluK2(Q) and WT 
GluK5 or GluK1(R). As shown in Fig. 9, cells cotransfected with 
either GluK1(R) or GluK5 together with GluK2(Q) A8C or GluK2(Q) 
L10C displayed currents that were activated by exposure to Cd 
alone as well as enhancement of KA-evoked current by Cd coap-
plication. Previous work suggests that formation of heteromeric 
receptors is strongly favored upon coexpression of GluK2 with 
GluK1 or GluK5 (Cui and Mayer, 1999; Wilding et al., 2005; Reiner 
et al., 2012); however, the possibility that sensitivity to Cd in these 
cells resulted from a minor population of homomeric GluK2(Q) 
A8C or L10C is difficult to rule out. Agonist- and Cd-evoked I-V re-
lations displayed inward rectification for cells cotransfected with 
mutant GluK2(Q) and WT GluK5 (data not shown), which encodes 
a Gln at the Q/R site and does not undergo editing (Traynelis et al., 
2010). In contrast, the I-V relations lacked inward rectification 
for cotransfections that included the GluK1(R) subunit (Fig. 9 B), 
supporting the heteromeric inclusion of edited GluK1(R) within 
Cd-sensitive receptors (Fig. 9, A and C). To provide additional ev-
idence that activation by Cd does not require A8C or L10C sub-
stitution on all four subunits within the tetramer, we analyzed 
substitution mutants of chimeric subunits that only form func-
tional receptors as coexpressed heteromers (Wilding et al., 2014).
Figure 7. Cd increases open probability. (A) Points show mean current 
(bottom) and current variance (top) for whole-cell responses evoked by 50 
and 500 µM Cd (dark and bright red, respectively), 10 µM kainate (green), and 
10 µM kainate + 50 µM Cd (cyan) in an HEK cell transfected with GluK2(Q) 
L10C. Holding potential is −80 mV. (B and C) Plots of current variance versus 
mean current evoked by 10 µM kainate, 50 or 500 µM Cd alone, or 10 µM 
kainate plus 50 µM Cd in HEK cells expressing homomeric GluK2(Q) L10C (B) 
or GluK2(R) A8C (C). Note the variance data in A and B are from the same cell 
and plotted on the same variance scale, in A as a function of time and in B as 
a function of the mean current values for each time segment. Smooth curves 
in B are the best fits of the parabolic equation σ2 = i * I − (I2/N), where σ2 is 
variance, I is the mean macroscopic current, i is the unitary current (∼0.1 pA), 
N is the number of channels (∼12,000), and maximum Po = Imax/(i * N) (∼0.5). 
Smooth curves in C are best straight line fits with slope = i (12 fA for kainate 
and 4 fA for 50 and 500 µM Cd).
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Cys substitutions to chimeric subunits
Because NMDA receptors are obligate heteromers (Traynelis et 
al., 2010), chimeric subunits in which the GluK2(Q) TMD and 
CTD are linked with the ATD and LBD of GluN1 or GluN2B do not 
generate functional channels when expressed alone in HEK cells 
but only when coexpressed (Wilding et al., 2014). As shown in 
Fig. 10, 50 µM Cd alone activated chimeric receptors with A8C 
substitution to either the N2B/K2(Q) (Fig.  10  A) or N1/K2(Q) 
(Fig. 10 B) subunit or to both subunits (Fig. 10 C). In contrast, cells 
expressing chimeric receptors with WT M3 residues (Fig. 10 D) 
and cells transfected with WT GluN1 plus GluN2B (Fig.  10  E) 
often displayed small reductions in holding current when ex-
posed to 50  µM Cd alone and partial block of agonist-evoked 
current, similar to the effects of Cd on WT GluK2 (Figs. 2 and 
3). Fig. 10, F and G, summarize results for WT and A8C mutant 
chimeric subunits during exposure to Cd alone (Fig. 10 F) or Cd 
plus agonist (Fig. 10 G). When expressed as a fraction of the cur-
rent evoked by agonist alone, responses to Cd alone or Cd plus 
agonist for chimeric receptors with A8C substitution to either 
the N1/K2(Q) or N2B/K2(Q) subunit were comparable to homo-
meric GluK2(Q) A8C and nearly as large as Cd responses observed 
for receptors with A8C substitution in both chimeric subunits 
(Fig. 10, F and G).
To test for possible differences in potency of Cd activation 
among chimeric receptors with either or both subunits bearing 
A8C substitutions, we evaluated the currents evoked by addi-
tional Cd concentrations. As shown in Figs. 10, A–C, and 11, A and 
B, exposure to Cd concentrations up to 50 µM yielded essentially 
monotonic current activation at the onset of Cd and monotonic 
decay on return to control solution. In contrast, currents elicited 
by higher Cd concentrations displayed a multiphasic time course 
characterized by an initial spike of inward current followed by 
decay to a lower steady-state plateau and a prominent tail cur-
rent on Cd wash out (Fig. 11 B), suggesting a composite response 
that includes a component of low-affinity block superimposed on 
current activation. For the summary plots in Fig. 11 D, the steady-
state currents during Cd exposure are normalized to the maximal 
peak inward current recorded at the onset or offset of treatment 
with 5 mM Cd. Based on this analysis summarized in Table 1, Cd 
activation was more potent at receptors that included A8C sub-
stitutions in both chimeric subunits (EC50 = 5.6 ± 1.7 µM) than for 
receptors in which A8C was only present in the N2B/K2(Q) sub-
unit (EC50 = 27 ± 9 µM) or the N1/K2(Q) subunit (EC50 = 47 ± 8 µM). 
In addition, block by higher Cd concentrations was substantially 
weaker for chimeric receptors that only included the A8C substi-
tution to the N1/K2(Q) chimera (IC50 = 13 ± 10 mM; Fig. 11 A) but 
significantly more potent for chimeric receptors that included the 
N2B/K2(Q)A8C subunit, either alone (Fig. 11 B) or together with 
N1/K2(Q)A8C (IC50 = 1.1 ± 0.2 mM; Fig. 11 D). For comparison, we 
also evaluated the concentration dependence of Cd inhibition at 
WT N1 + N2B NMDA receptors as well as chimeric receptors with 
WT M3 residues. As shown in Fig. 12, inhibition observed during 
exposure to 10 µM NMDA and glycine was stronger for receptors 
lacking the A8C substitution, being half-maximal at 200 µM Cd 
for WT NMDA receptors and 400 µM for chimeric receptors.
As for homomeric GluK2 (Fig. 4 A, inset), we also used expo-
nential fits to the monotonic rise and decay of current observed 
with exposure to 50 µM Cd to determine the onset and recovery 
time constants for current activation (Table 2). Kinetics of inhi-
bition were estimated from the biphasic onset and recovery cur-
rents recorded upon exposure to high Cd concentrations, which 
were fit with the sum of two exponentials. Fig. 11 C shows an ex-
ample for chimeric receptors that included N2B/K2(Q)A8C, ex-
panded from the trace in Fig. 11 B, with the onset fit (red curve) 
Table 3. Unitary parameters estimated from fluctuation analysis
Kainate Cd Cd Kainate + Cd
10 µM 50 µM 500 µM 10 + 50 µM
GluK2(Q) L10C
Unitary current (fA) 92 ± 8 83 ± 13 76 ± 11 79 ± 9
Unitary conductance (pS) 1.15 ± 0.10 1.04 ± 0.16 0.94 ± 0.14 0.99 ± 0.11
g Cd/g K 0.93 ± 0.07 0.81 ± 0.05 0.85 ± 0.04
Maximal current (pA) 212 ± 38 75 ± 4 218 ± 18 412 ± 38
Open probability 0.21 ± 0.03 0.09 ± 0.02 0.30 ± 0.05 0.48 ± 0.03
Po Cd/Po K 0.4 ± 0.1 1.7 ± 0.5 3.9 ± 1.3
Number of cells 10 8 9 10
GluK2(R) A8C
Unitary current (fA) 15.7 ± 3.0 4.4 ± 0.9 4.0 ± 0.7
Unitary conductance (fS) 197 ± 37 55 ± 11 50 ± 9
g Cd/g K 0.39 ± 0.07 0.32 ± 0.08
Maximal current (pA) 473 ± 158 1,350 ± 300 860 ± 130
Po Cd/Po K 27 ± 13 20 ± 6
Number of cells 16 16 9
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providing estimates for the time constant of current activation 
(τ1) and block (τ2) and the recovery fit (blue curve) yielding esti-
mates for the time constant of unblock (τ3) and deactivation (τ4). 
We used the time constants determined for N1/K2 + N2B/K2 A8C 
(Table 2) to construct kinetic models (Fig. S3 and Table 3) that 
reproduce several features of Cd activation and block observed for 
the three chimeric subunit combinations analyzed in Fig. 11. The 
models assume that binding of either one or two Cd ions supports 
activation of receptors with A8C substitutions to both the N1/K2 
and N2B/K2 subunits, whereas receptors with only one of the two 
chimeric subunits bearing an A8C mutation can only bind a single 
activating Cd. Inhibition is modeled by independent binding of up 
to four additional Cd ions to lower-affinity sites. The same set of 
rate constants for activation (kon = 17,500 mol−1 s−1, koff = 0.39 s−1), 
inhibition (kon = 240 mol−1 s−1, koff = 2 s−1), and channel opening 
(β = 50 s−1, α = 200 s−1) define the models for all three construct 
combinations: N1/K2 A8C + N2B/K2 (model 1 + 2), N1/K2 + N2B/
K2 A8C (model 1 + 4), and N1/K2 A8C + N2B/K2 A8C (model 2 + 4).
As shown in Fig. 13, current activation by Cd alone and syn-
ergy between Cd and kainate was also observed for chimeric re-
ceptors with L10C substitutions to either the N1/K2(Q) or N2B/
K2(Q) subunit or both. Comparing the results for receptors with 
A8C or L10C substitutions (Figs. 10 F and 13 B) confirmed a sig-
nificantly larger effect by 50 µM Cd on receptors with Cys sub-
stitution to all four chimeric subunits in the tetramer (two-way 
ANO VA). For each of the construct combinations, however, post 
hoc pairwise comparison indicated no significant difference 
in 50 µM Cd effect between the A8C and the L10C substitution 
(Student–Newman–Keuls test). Collectively, the results in Figs. 
10, 11, 12, and 13 confirm that substitution to all four subunits 
in the tetramer is not required for sensitivity to Cd at either the 
A8 or L10 positions. In addition, these experiments demonstrate 
similar activation by Cd for substitutions to either the N1/K2 or 
N2B/K2 chimeric subunits, suggesting nearly symmetrical inter-
action between subunits in either the A/C or B/D conformations, 
respectively (Wilding et al., 2014).
Mutation of potential coordination partners
The apparent potency of Cd activation of receptors with A8C sub-
stitutions in the 10–50 µM range (Fig. 10 D) is consistent with Cd 
Figure 8. Cd sensitivity requires Cys substitution. (A and B) Summary 
plots of current (mean ± SEM) evoked by 50 µM Cd alone (A) or 10 µM kainate 
plus 50 µM Cd (B) as a fraction of current evoked by 10 µM kainate alone for 
A8 substitution with C, S, T, F, or Y. Asterisk denotes significant difference 
from S, T, F, or Y (ANO VA on ranks with post hoc Dunn’s test, 5–114 [A] or 
3–17 [B] cells per construct). (C) After brief exposure to 100 µM MTS EA (blue 
bar) together with 10 µM kainate (open bars), the holding current and current 
evoked by 10 µM kainate were increased, whereas current evoked by 50 µM 
Cd alone (red bars) or with 10 µM kainate (cyan bars) was reduced. (D and E) 
Summary plots of current (mean ± SEM) evoked by Cd alone or with kainate, 
by kainate alone, and the holding current after MTS EA as a fraction of current 
before MTS EA for GluK2(Q) A8C (D; six cells) or L10C (E; six cells). Asterisk 
denotes significant difference from I post = I pre (t statistic, P < 0.01).
Figure 9. Cd activates heteromeric kainate receptors. (A) Whole-cell cur-
rents evoked by 10 µM kainate (open bars) and 500 or 50 µM Cd alone (red 
bars) or together with 10 µM kainate (mauve and cyan bars, respectively) in a 
cell cotransfected with GluK2(Q) L10C and GluK1(R). (B) Lack of inward recti-
fication in current–voltage relations from the same cell shown in A supports 
formation of heteromeric receptors. (C) Summary plots of current (mean ± 
SEM) evoked by 50 µM Cd alone (left; 10–114 cells per construct) or 50 µM 
Cd plus 10 µM kainate (right; 9–17 cells) as a fraction of kainate alone in cells 
transfected with GluK2(Q) alone or cotransfected with GluK2(Q) A8C or L10C 
together with either GluK1(R) or GluK5. Note the log scale. Asterisk denotes 
significant difference from homomeric GluK2(Q) A8C or L10C.
Wilding and Huettner 
Cd activates Cys-substituted kainate receptors
Journal of General Physiology
https://doi.org/10.1085/jgp.201812234
445
coordination by two or more side chains (Puljung and Zagotta, 
2011; Zhou et al., 2015). The most likely coordination partners in-
clude His, Glu, Asp, or other Cys residues (Rulíšek and Vondrášek, 
1998), although interactions involving other polar residues as 
well as backbone carbonyls are also possible. To test for potential 
coordination partners, we have begun making substitutions to 
likely candidate residues that are located near the A8 position in 
GluK2 homology models (Lopez et al., 2013) and cryo-EM structures 
Figure 10. Cadmium activation of chimeric receptors with A8C substitu-
tions. (A–C) Whole-cell currents evoked by 10 µM NMDA plus 10 µM glycine 
(open bars) or by 50 µM Cd alone (red bars) in HEK cells cotransfected with 
chimeric subunits bearing A8C substitutions on the N2B/K2(Q) subunit (A), 
on the N1/K2(Q) subunit (B), or on both chimeric subunits (C). (D and E) Chi-
meric receptors lacking cysteine substitution (D) and WT (N1 + N2B) NMDA 
receptors (E) were not activated by Cd alone, and coapplication of Cd (cyan 
bars) inhibited agonist-evoked current. (F and G) Summary plots of current 
evoked by Cd alone (F; 9–114 cells per construct) or together with agonists (G; 
6–17 cells) as a fraction of the current evoked by agonists alone (mean ± SEM). 
The first four positions plot results for chimeric receptors. For comparison, 
GluK2(Q) WT and A8C results are replotted from Fig. 1 followed by WT GluN1 + 
GluN2B. Note the y-axis log scale. Asterisk denotes significantly greater effect 
of 50 µM Cd on receptors with A8C substitution to both chimeric subunits 
(one-way ANO VA with post hoc Student–Newman–Keuls test), # indicates 
significant inhibition of kainate-evoked current by Cd (t statistic), and ns indi-
cates no significant increase in holding current by Cd alone (t statistic).
Figure 11. Concentration dependence of chimeric A8C mutant receptor 
activation. (A and B) Whole-cell currents evoked by Cd (5 and 1 mM and 500, 
50, 5, and 0.5 µM) in cells transfected with N1/K2 A8C + N2B/K2 (A) or N1/
K2 + N2B/K2 A8C (B). Chimeric receptors were both activated and blocked 
by the highest Cd doses tested, with stronger block observed for channels 
that included the N2B/K2 A8C subunit (B). (C) Currents from the onset and 
termination of 5 mM Cd exposure in B shown on an expanded time scale and 
fit with the sum of two exponentials (superimposed smooth curves). Expo-
sure onset (red curve) includes time constants for activation (τ1 = 50 ms) and 
onset of block (τ2 = 0.2 s). On return to control solution (blue curve), receptors 
unblock (τ3 = 0.5 s) and deactivate (τ4 = 8 s). (D) Plot of steady-state current 
(mean ± SEM) during exposure to Cd as a fraction of the maximal Cd-evoked 
response, usually the peak tail current at termination of exposure to 5 mM Cd. 
Smooth curves are the best fit of (Materials and methods) I/Imax = m + ((1/(1 + 
(EC50/[Cd])n) − m)/(1 + ([Cd]/IC50)b)). For N1/K2A8C + N2B/K2 (blue triangles; 
14 cells) the EC50 = 47 ± 8 µM, n = 1.0 ± 0.2, IC50 = 13 ± 10 mM, b = 0.9 ± 0.4, 
and the minimum parameter (m) was set to zero. Curves for N1/K2 + N2B/
K2A8C (red inverted triangles; 14 cells) and N1/K2A8C + N2B/K2A8C (violet 
squares; 21 cells) show simultaneous fits constrained to have the same IC50 = 
1.1 ± 0.2 mM, b = 1.8 ± 0.4, n = 0.9 ± 0.1, and m = −0.43 ± 0.12 with different 
EC50 values 27 ± 9 µM and 5.6 ± 1.7 µM, respectively. Individual fits requiring 
three additional free parameters were not significantly better (F test).
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(Meyerson et al., 2016). There are no His residues near the GluK2 
bundle crossing; therefore, our initial experiments focused on 
three negatively charged Glu residues in the S2–TMD linkers 
within 15 Å of the A8C side chain, as well as two Cys residues 
slightly farther away in the M1 helix. The plots in Fig. 14 show 
that activation by Cd persisted in receptors where these residues 
have been replaced individually or in combinations. Collectively, 
these results demonstrate that coordination of Cd between A8C 
and any of these side chains is not required for activation. 
Instead, coordination may involve neutral polar side chains, 
backbone carbonyl groups, or negatively charged residues 
more distant than 15 Å in currently available structures. Alter-
natively, Cd might coordinate between the substituted A8C side 
chains, although this would position Cd along the pore axis, 
which might be expected to impede ion flux (Discussion). Addi-
tional experiments will be needed to determine which of these 
various alternatives underlies coordination responsible for acti-
vation of A8C mutants by Cd.
Discussion
Recent work on iGluR gating has focused on the LBD–TMD linkers 
and the extracellular ends of the M1, M3, and M4 helices as loci 
for disease-causing mutations (Guzmán et al., 2017; Fry et al., 
2018) and as targets for iGluR subtype-selective allosteric mod-
ulators (Yelshanskaya et al., 2016; Wang et al., 2017; Perszyk et 
al., 2018). The recognized importance of this region for control 
of channel gating has fueled recent mutagenesis work analyzing 
the structural requirements for mechanical coupling between 
the LBD and TMD (Alsaloum et al., 2016; Yelshanskaya et al., 2017; 
Ladislav et al., 2018). In the present study, we have identified two 
positions near the extracellular end of the M3 helix where cyste-
ine substitution renders GluK2 kainate receptors susceptible to 
direct activation by exposure to Cd. One site is homologous to the 
location of the A8T point mutation in the iGluR delta subunit of 
Lurcher mice (Zuo et al., 1997; Kohda et al., 2000). The other site 
is a leucine located two residues farther along the M3 helix (L10), 
a rotation of 200° around the helical axis (Fig. 15 A). Our experi-
ments demonstrate that strong activation by Cd is specific to Cys 
substitution and that exposure to Cys-reacting MTS reagents can 
occlude the effects of Cd. These results provide evidence that the 
introduced Cys residues directly interact with Cd but do not re-
solve whether coordination by additional side chains is required 
Figure 12. Cd inhibits chimeric and WT NMDA receptors. (A and B) 
Whole-cell currents evoked by 10 µM NMDA and 10 µM glycine (open bars) 
in HEK cells transfected with GluN1wt and GluN2Bwt cDNA (A) or with N1/
K2(Q) and N2B/K2(Q) cDNA (B). Cd was coapplied at 3.2, 16, 80, or 400 µM 
or at 2 or 10 mM as indicated by the solid bars. (C) Current (mean ± SEM) 
recorded during Cd coapplication as a fraction of control current immediately 
before Cd exposure (six WT and eight chimera cells). Smooth curves are the 
best fit of I/Icontrol = m + (1 − m)/(1 + ([Cd]/IC50)n).
Figure 13. Cd activation of chimeric receptors with L10C substitutions. 
(A) Whole-cell currents activated by 10 µM NMDA plus 10 µM glycine (open 
bars) or 50 µM, 500 µM, or 5 mM Cd alone (red bars) or together with agonist 
(cyan bars). (B) Current (mean ± SEM) evoked by Cd alone (left; 5–15 cells 
per construct) or agonist plus Cd (right; 5–14 cells) as a fraction of current 
evoked by 10 µM NMDA plus 10 µM glycine. Note the y-axis log scale. Aster-
isk denotes significantly greater effect for receptors with L10C substitution 
to both chimeric subunits at each Cd dose (one-way ANO VA with post hoc 
Student–Newman–Keuls test), # indicates significant inhibition of kain-
ate-evoked current by Cd (t statistic), and ns indicates no significant increase 
in holding current by Cd alone (t statistic).
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for channel activation. The difference in potency for Cd activa-
tion of channels with A8C or L10C substitutions suggests that dis-
tinct mechanisms may be involved. The EC50 values in the range 
of 5–10 µM that we observed for receptors with A8C substitu-
tions on all four subunits are consistent with a Cd binding site in-
volving at least two coordinating residues (Puljung and Zagotta, 
2011), whereas the weaker potency for activation of homomeric 
GluK2(Q) L10C (EC50 ∼2 mM) suggests that tight coordination by 
multiple residues is not required for Cd activation of channels 
bearing this mutation. For the L10C substitution, channel modi-
fication by MTS EA occluded activation by Cd but also produced 
changes that were similar to the effects observed during Cd ex-
posure, including a substantial increase in the holding current 
as well as in kainate-evoked current. This result suggests that 
addition of positive charge at this location, which could serve to 
destabilize hydrophobic bundle crossing occlusion, has a similar 
effect on channel properties whether it results from the Cys side 
chain binding Cd or undergoing covalent modification by MTS 
EA. In contrast, for the A8C substitution, MTS EA occluded the 
action of Cd without significant change in holding current or ac-
tivation by kainate, suggesting that addition of positive charge 
alone is not sufficient at this location and coordination by multi-
ple residues may be necessary.
Previous work (Rulíšek and Vondrášek, 1998) indicates a bond 
length of ∼2.6 Å between Cd ions and the terminal sulfur of Cys 
side chains, suggesting that other coordination partners would 
need to be relatively close to the A8C or L10C positions, at least 
in the Cd-bound activated state. Analysis of metal ion binding 
sites across a wide array of proteins (Holm et al., 1996; Rulíšek 
and Vondrášek, 1998) suggests that the most likely coordination 
partners include histidine (Holmgren et al., 1998) or other free 
cysteine residues (Liu et al., 1997; Sobolevsky et al., 2002), as 
well as negatively charged glutamate or aspartate (Veran et al., 
2012; Zhou et al., 2015), and with lower-frequency polar serine, 
threonine, or tyrosine residues or backbone carbonyls (Holm et 
al., 1996; Rulíšek and Vondrášek, 1998). As an initial screen for 
potential coordination partners, we generated substitutions 
that replaced Cys residues in the M1 helix or negatively charged 
Glu side chains in the M3–S2 and S2–M4 linkers within 15 Å of 
A8C; however, these changes failed to eliminate Cd activation of 
GluK2(Q) A8C, suggesting that these residues are not essential 
for direct coordination of Cd. Conformational changes associ-
ated with channel opening by Cd might bring other possible co-
ordination partners within closer proximity of the A8C or L10C 
substitutions, but further experiments will be needed to deter-
mine whether any other residues more distant from the A8C or 
L10C are required.
Our results with heteromeric kainate receptors and recep-
tors formed by coexpression of chimeric subunits demonstrate 
that activation by Cd does not require Cys substitution to all four 
subunits in the tetramer, although for the A8C substitution, Cd 
potency was shown to be lower for receptors with fewer M3 A8C 
replacements. Cd activated chimeric receptors with A8C sub-
stitutions in both the N1/K2 and N2B/K2 subunits with an EC50 
of ∼6 µM, which was similar to the EC50 of 10 µM observed for 
homomeric GluK2 A8C. In contrast, Cd was ∼5- to 10-fold less 
potent for activation of chimeric receptors in which the A8C 
substitution was only present on the N2B/K2 (EC50 = 27 µM) or 
Figure 14. Potential coordination partners not required 
for Cd activation. (A) Whole-cell current 10 µM kainate (open 
bars), 50 µM Cd alone (red bar), and 5 or 50 µM Cd together 
with kainate (cyan bars) in an HEK cell transfected with triple 
mutant GluK2(Q) A8C, E13A (in the M3–S2 linker), and E811A (in 
the S2–M4 linker). (B and C) Summary plots of current (mean 
± SEM) evoked by Cd alone (B; 4–114 cells per construct) or Cd 
plus kainate (C; 4–17 cells) as a fraction of the current evoked by 
kainate alone (note the y-axis log scale).
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the N1/K2 (EC50 = 47 µM) subunit. Given that WT receptors show 
no activation for up to 5 mM Cd, we estimate a coupling energy 
(ΔΔG) of at least 3 kT (∼1.9 kcal/mol) for A8C substitution of the 
two chimeric subunits.
Our numerical simulations suggest that relatively simple ki-
netic models are at least qualitatively consistent with activation 
and inhibition of chimeric receptors by Cd. The models include 
channel activation by binding one or two Cd ions depending on 
whether the A8C substitution was present on one or both of the 
GluN/GluK2 chimeric subunits, whereas inhibition results from 
two or four additional lower-affinity Cd binding steps. In the 
present case, state transitions in all of the models were defined 
by the same set of four rate constants, which corresponds to an 
assumption that all interactions are symmetrical and indepen-
dent. Further simulations may provide a better quantitative fit to 
experimental recordings by modifying individual rate constants 
to incorporate positive or negative cooperativity between the 
various binding steps or to reflect possible asymmetry between 
A8C substitution to the N1/K2 or N2B/K2 chimeric subunits.
From previous work on block of GluA1 A7C AMPA receptors 
it has been suggested that metal ions can coordinate between in-
troduced M3 Cys residues on adjacent subunits (Sobolevsky et al., 
2004). Although this might explain Cd interaction with receptors 
that have Cys substitution in all four subunits of the tetramer, 
it seems less likely to hold for heteromeric combinations with 
Cys substitution on only two of the four subunits. In particular, 
the N1–N2–N1–N2 alternating arrangement of native NMDA 
receptors (Salussolia et al., 2011; Riou et al., 2012; Karakas and 
Furukawa, 2014; Lee et al., 2014) predicts that our heteromeric 
chimeric receptors with A8C or L10C substitution in only the N1/
K2 or only the N2B/K2 subunit would not present Cys residues on 
adjacent subunits but instead introduce Cys side chains displayed 
diagonally across the central axis with a separation distance of 
12–14 Å in currently available closed and open state structures 
(Sobolevsky et al., 2009; Meyerson et al., 2016; Chen et al., 2017; 
Twomey et al., 2017). Although we cannot rule out coordination 
across the diagonal between Cys substitution to subunits in the 
A and C conformation (N1/K2 chimera) or the B and D confor-
mation (N2B/K2 chimera), such a mechanism would appear to 
require substantial M3 reorientation and would locate the coor-
dinated Cd ion directly along the central axis.
Recent work on the presumed open conformation of homo-
meric GluA2 AMPA receptors (Chen et al., 2017; Twomey et al., 
2017) has described substantial deformations in the M3 helix of 
subunits in the B and D conformation with more limited changes 
to the A and C subunits. In particular, the M3 helix remains 
straight in the open state A and C conformations, whereas the B 
and D subunits exhibit a notable kink at the A4 position (Chen et 
al., 2017; Twomey et al., 2017), which precedes the A8C and L10C 
substitutions studied here. Fig. 15, B and C, depict axial and side 
views of a GluK2 A8C homology model based on the AMPA recep-
tor open state structure. The A8C side chains reside closer to the 
pore axis than L10, which may contribute to the lower conduc-
tance ratios (g Cd/g K) observed for Cd bound to A8C compared 
with L10C. Although it remains to be determined whether M3 
helix structural deformations occur in the open states of homo-
meric GluK2 or the GluN/GluK2 chimeric subunits, the modest 
functional asymmetry we observe for Cd activation and inhibi-
tion of A8C and L10C substitutions to N1/K2 or N2B/K2, together 
with the lower estimated unitary conductance for channels acti-
vated by Cd, suggest that the open states induced by Cd binding 
may be distinct from the native open conformation.
In contrast to cells transfected with WT GluK2, some of the 
cells expressing WT N1 + N2B or chimeric subunits with WT M3 
residues displayed a reduction in holding current or inhibition 
beyond the initial holding level during exposure to millimolar 
Cd. For receptors bearing mutations that destabilize the bundle 
crossing, this effect at high Cd concentrations probably reflects 
inhibition of constitutive current mediated by the transfected 
receptors in the nominal absence of agonist. Our previous work 
(Wilding et al., 2014) showed that activation of receptors formed 
by chimeric subunits lacks the tight requirement for occupation 
of both NMDA and glycine sites observed with full-length WT 
subunits (Traynelis et al., 2010), suggesting that stray levels of 
glycine may be sufficient for chronic partial activation of chime-
ric receptors (Wilding et al., 2014). For cells transfected with WT 
NMDA receptor subunits, it remains to be determined whether 
all of the current blocked by millimolar Cd is mediated directly by 
NMDA receptors or whether expression of these receptors may 
enhance other Cd-sensitive currents, possibly by persistent ele-
vation of cytoplasmic calcium levels.
Figure 15. The M3 helix positions that support activation by Cd. (A) The 
M3 helical wheel from isoleucine (−1) to glutamate (+13). Circle diameters pro-
portional to side chain volume. Colors denote side chain properties: negative 
charge (red), polar (blue), aromatic (green), hydrophobic (black), and cysteine 
substitution at positions 8 and 10 (yellow). (B) Semitransparent view down 
the open state model TMD axis illustrating A7, A8C, and L10 side chains. (C) 
The TMD side view of two GluK2 A8C open state homology model subunits in 
the C (blue) and D (yellow) conformations rotated 90° from B. The A7, A8C, and 
L10 side chains are shown as sticks. Vertical gray arrow denotes the central 
axis with the backbone cartoon semitransparent. A higher-resolution view of 
the boxed region is shown on the right.
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Increasing evidence implicates a role for kainate receptors in 
nociception (Bhangoo and Swanson, 2013) and neural develop-
ment (Guzmán et al., 2017) as well as neuropathologies includ-
ing epilepsy (Crépel and Mulle, 2015) and psychiatric disorders 
(Lerma and Marques, 2013). Better understanding of how these 
receptors operate should aid in the design of therapeutic agents. 
Our experiments demonstrate that Cd binding can directly 
open channels with Cys substitutions at two positions near the 
inner helix bundle crossing, circumventing the requirement 
for agonist site occupation. At one of the sites (L10C), Cd bind-
ing acts synergistically with agonist, and tight coordination of 
Cd is not required. In contrast, we saw no evidence for synergy 
with agonist for channel activation by Cd coordination at the 
A8C substitution two residues preceding L10. The A8 position is 
homologous to the delta subunit residue where gain of function 
mutations produce cerebellar ataxia both in humans (Coutelier 
et al., 2015) and in the Lurcher mutant mouse strain (Zuo et al., 
1997). More recently, de novo A8T mutation in human GRIK2, 
which encodes the GluK2 subunit, was shown to underlie a set 
of human neurodevelopmental deficits including ataxia and in-
tellectual disability (Guzmán et al., 2017). Additional work on M3 
helix substitutions should help further elucidate the conforma-
tional changes that mediate iGluR gating in health and disease.
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Figure S1. Cd activation does not require increased agonist potency. (A) Whole-cell currents evoked by 100 µM kainate (open bars) or 50 µM Cd (red 
bars) in cells transfected with GluK2(Q) A8C and GluK2(Q) A8C E738D. (B) Current (mean ± SEM) evoked by 50 µM Cd as a fraction of 100 µM kainate for 
GluK2(Q) A8C (open bar; 9 cells) and GluK2(Q) A8C E738D (solid bar; 37 cells). (C) Plots of normalized kainate-evoked current (mean ± SEM) for GluK2(Q) A8C 
E738D (solid squares; 15 cells), as well as GluK2(Q) A8C (open squares) and GluK2(R) WT (open circles) from Fig. 5. The EC50 for GluK2(Q) A8C E738D of 28 ± 
5 µM (n = 1.6 ± 0.2) indicates potency 233-fold lower than for GluK2(Q) A8C (EC50 = 120 nM).
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Figure S2. Cd inhibits GluK2 A8S, T, Y, or F. (A) Whole-cell current evoked by 10 µM kainate (open bars) was inhibited by Cd coapplication (cyan bars), and 
increasing concentrations of Cd alone (red bars; 50 µM, 500 µM, and 5 mM Cd) produced a dose-dependent reduction in the holding current in an HEK cell 
transfected with GluK2(R) A8T. (B and C) Summary plots of current (mean ± SEM) recorded during exposure to Cd alone (B) or Cd plus kainate (C) as a frac-
tion of current evoked by kainate alone for homomeric receptors with S, T, F, or Y substitution at A8 (4–30 cells per construct).
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Figure S3. Kinetic models for Cd activation and inhibition. (A) Schemes for activation by one Cd and inhibition by two Cd (1 + 2), activation by one Cd 
and inhibition by four Cd (1 + 4), and activation by two Cd and inhibition by four Cd (2 + 4). Rate constants for activation (k1, k2) and block (k3, k4) were 
chosen for the 1 + 4 scheme to approximate the time constants observed with the N1/K2 + N2B/K2 A8C chimera for activation by 50 µM Cd and inhibition 
by 5 mM Cd, respectively (Table 2). Rates for opening and closing (β, α) were set to yield a maximal open probability of 0.2 (Fig. 7). Solution exchange was 
assumed to occur with a time constant of 0.1 s for both onset and recovery. (B and C) Numerical simulations of open probability as a function of time for 10 s 
exposure to increasing concentrations of Cd and 20 s recovery for scheme 1 + 4 (B) or schemes 2 + 4 (C; black traces) and 1 + 2 (C; light blue traces). Note that 
the same rate constants were used for all three schemes. Red and dark blue lines show single exponential fits to the activation and recovery phases for 50 µM 
Cd and sums of two exponentials fit to the onset (red) and recovery (blue) phases for exposure to 5 mM Cd. (D and E) Plots of activation at the end of 10 s 
Cd exposure as a function of Cd concentration. In D, the points are normalized to the maximal Po as in Fig. 11; E plots the raw steady-state Po values for the 
three schemes. Smooth curves in D are best fits of I/Imax = (1/(1 + (EC50/[Cd])n)/(1 + ([Cd]/IC50)b)). The same equation multiplied by a scaling factor was fit in 
E. Table S1 presents fit parameters for the numerical simulations to allow comparison with experimental results in Tables 1 and 2.
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Scheme Activation (s) [Cd] (mM) Inhibition (s) [Cd] (mM) EC50 (µM) Slope, n IC50 (mM) Slope, b
Tau on Tau off Tau on Tau off
2 + 4 0.74 3.92 0.05 6.5 1.3 2.0 1.6
0.05 2.98 5 0.26 0.96 5
1 + 2 0.96 3.23 0.05 13.8 1.2 5.0 1.4
0.04 3.13 5 0.31 0.53 5
1 + 4 0.98 3.24 0.05 12.4 1.3 2.3 1.8
0.04 3.32 5 0.25 0.68 5
Table S1. Parameters derived from kinetic model simulations
